key: cord-0879069-zxbmuxpw authors: Hoque, M. Nazmul; Rahman, M. Shaminur; Ahmed, Rasel; Hossain, Md. Sabbir; Islam, Md. Shahidul; Crandall, Keith A; Islam, Md Tofazzal; Hossain, M. Anwar; Siddiki, AMAM Zonaed title: Diversity and genomic determinants of the microbiomes associated with COVID-19 and non-COVID respiratory diseases date: 2020-10-19 journal: bioRxiv DOI: 10.1101/2020.10.19.345702 sha: 78c8953078fdf905192c4cb88ece749bf8d046f7 doc_id: 879069 cord_uid: zxbmuxpw The novel coronavirus disease 2019 (COVID-19) is a rapidly emerging and highly transmissible disease caused by the Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2). Understanding the microbiomes associated with the upper respiratory tract infection (URTI), chronic obstructive pulmonary disease (COPD) and COVID-19 diseases has clinical interest. We hypothesized that the diversity of microbiome compositions and their genomic features are associated with different pathological conditions of these human respiratory tract diseases (COVID-19 and non-COVID; URTI and COPD). To test this hypothesis, we analyzed 21 whole metagenome sequences (WMS) including eleven COVID-19 (BD = 6 and China = 5), six COPD (UK = 6) and four URTI (USA = 4) samples to unravel the diversity of microbiomes, their genomic features and relevant metabolic functions. The WMS data mapped to 534 bacterial, 60 archaeal and 61 viral genomes with distinct variation in the microbiome composition across the samples (COVID-19>COPD>URTI). Notably, 94.57%, 80.0% and 24.59% bacterial, archaeal and viral genera shared between the COVID-19 and non-COVID samples, respectively, however, the COVID-19 related samples had sole association with 16 viral genera other than SARS-CoV-2. Strain-level virome profiling revealed 660 and 729 strains in COVID-19 and non-COVID sequence data, respectively and of them 34.50% strains shared between the conditions. Functional annotation of metagenomics sequences of thevCOVID-19 and non-COVID groups identified the association of several biochemical pathways related to basic metabolism (amino acid and energy), ABC transporters, membrane transport, replication and repair, clustering-based subsystems, virulence, disease and defense, adhesion, regulation of virulence, programmed cell death, and primary immunodeficiency. We also detected 30 functional gene groups/classes associated with resistance to antibiotics and toxic compounds (RATC) in both COVID-19 and non-COVID microbiomes. Furthermore, a predominant higher abundance of cobalt-zinc-cadmium resistance (CZCR) and multidrug resistance to efflux pumps (MREP) genes were detected in COVID-19 metagenome. The profiles of microbiome diversity and associated microbial genomic features found in both COVID-19 and non-COVID (COPD and URTI) samples might be helpful for developing the microbiome-based diagnostics and therapeutics for COVID-19 and non-COVID respiratory diseases. However, future studies might be carried out to explore the microbiome dynamics and the cross-talk between host and microbiomes employing larger volume of samples from different ethnic groups and geoclimatic conditions. along the floor of the nasal passage up to the posterior wall of the nasopharynx, and rubbed against 143 and above the nasal turbinate. The swab was rotated a few times against the nasal wall before 144 removing. A second swab was used to abrade the tonsils and pharynx. The swabs were placed in 145 sample collection vial containing normal saline, and preserved at -80 °C until further use for RNA 146 extraction. The confirmatory diagnosis of SARS-CoV-2 infections were made by RT-qPCR (Péré 147 et al., 2020). 149 We further intended to characterize the microbial community present along with the SARS- Illumina artifacts, and phiX. Any sequence below these thresholds or reads containing more than 179 one 'N' were discarded. In the current study, 46.04 million reads in two metagenomes with an 180 average of 2.19 million reads per sample passed the quality control steps (Supplementary Data 1). 181 The trimmed sequences were uploaded to the MG-RAST server with properly embedded metadata 182 and were subjected to optional quality filtering with dereplication and host DNA removal, and 183 finally screening for taxonomic and functional assignment. Alpha diversity (diversity within 184 diversity, P=0.021, Kruskal-Wallis test) of respiratory tract microbiome (Fig. 1) . The rarefaction 219 curves showed that sequencing depth was sufficient to capture the entire microbial diversity among 220 the samples of the study (Fig. S1 ). Both the number of identified microbial taxa and Shannon 221 estimated alpha diversity were significantly higher in COVID-19 samples (BD and China) than 222 the non-COVID (UK and USA) samples (Fig. 1A) . The principal coordinate analysis based on 223 Bray-Curtis distances showed distinct separations among the four sampling locations (Bangladesh, 224 China, USA, and UK) (Fig. 1B) . Notably, the COVID-19 related samples (BD and China) 225 remained more similar than the URTI and COPD-associated samples from the USA and UK (Fig. 226 1B). Moreover, across the non-COVID respiratory diseases (URTI and COPD)-associated samples 227 of UK and USA, all of the samples clustered more closely than those of COVID-19 samples (BD 228 and China) indicating that SARS-CoV-2 infections are associated with diverse secondary 229 microbial communities (Fig. 1B) . (URTI; USA and COPD; UK)-related microbiomes at the domain level was dominated by bacteria, 232 with a relative abundance of >99.50, followed by archaea (~ 0.3%), and viruses (~0.2%) (Data 233 S1). Twenty-eight bacterial phyla were identified in COVID-19 (BD and China), and non-COVID 234 (UK and USA) metagenomes including 28, 10, 28 and 27 phyla in BD, China, UK and USA 235 samples, respectively (Data S1). A total of 534 bacterial genera were detected across the four archaeal genera, majority of the genera (80.0%) were found to be shared in both sample groups, 243 and only 20.0% (12/60) archaeal genera had unique association with non-COVID diseases ( Fig. 244 2B, Data S1). Similarly, 26.23% and 49.18% of the detected viral genera had unique association 245 with COVID-19 and non-COVID diseases, respectively, and 24.59% genera were found to be 246 shared between the conditions (Fig. 2C , Data S1). The strain level profiling of the viral 247 communities revealed 1032 strains including 660 and 729 in the COVID-19 and non-COVID 248 samples, respectively (Fig. 2 D, Data S1 ). Of the identified strains, 303 in COVID-19 and 373 in 249 non-COVID respiratory disease samples, respectively had unique associations, and 34.50% strains 250 were found to be shared between the conditions (Fig. 2 D (2.38%) in non-COVID samples ( Fig. 3 ; Data S1). The rest of the phyla in four geographic 258 locations had relatively lower abundances (< 1.0%) (Data S1). The composition and relative abundance of the bacteria significantly differed (P = 0.029, (1.24%), and Bifidobacterium (1.05%) were the predominantly abundant genera in non-COVID 273 (COPD and URTI) samples of the UK and USA (Fig. 4 , Data S1). The rest of the genera detected abundances (Data S1). 277 The archaeal and viral fractions of microbiomes in COVID-19 (BD and China), and non-278 COVID respiratory disease (COPD; UK and URTI; USA)-samples were concomitantly detected. The composition and relative abundance of these two domains varied significantly (P = 0.017, as Data S1 and S2, and Figure S1 . Kruskal-Wallis test). disease, and the last two bar plots depict overall relative abundance of phyla in COVID-19 and non-COVID 844 metagenomes, respectively. The distribution and relative abundance of the bacterial phyla in the study 845 metagenomes are also available in Data S1. Genome-wide analysis of SARS-688 CoV-2 virus strains circulating worldwide implicates heterogeneity Optimization of alignment-691 based methods for taxonomic binning of metagenomics reads New approach for 694 understanding genome variations in KEGG Lung microbiome and coronavirus disease 2019 (COVID-696 19): Possible link and implications An adaptive microbiome α-diversity-based association analysis method Paradigms of lung microbiota functions in health and 729 disease, particularly, in asthma Coronavirus infections-more than just the 731 common cold Nasal swab sampling for SARS-CoV-2: a Comparing SARS-CoV-2 with SARS-CoV and 738 influenza pandemics. The Lancet infectious diseases Global chemical effects of the microbiome 741 include new bile-acid conjugations Comprehensive annotations of the mutational spectra of SARS-CoV-2 spike protein: a 745 fast and accurate pipeline Epitope-based 748 chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic 749 agent of global pandemic COVID-19: an in silico approach Time-course of upper respiratory tract viral infection 764 and COPD exacerbation COVID-19 and immunosuppression: 767 a review of current clinical experiences and implications for ophthalmology patients 768 taking immunosuppressive drugs Metagenomics 770 and transcriptomics data from human colorectal cancer Identification of a pangolin niche for a 2019-nCoV-like coronavirus through an extensive 773 meta-metagenomic search Microbiota composition in upper respiratory tracts of healthy children in Shenzhen China, differed with respiratory sites and ages The influence of the 781 microbiome on respiratory health Influenza A virus infection impacts systemic microbiota dynamics and causes 784 quantitative enteric dysbiosis Characterization of antibiotic resistance and 787 host-microbiome interactions in the human upper respiratory tract during influenza 788 infection Mining, analyzing, and integrating viral signals from 791 metagenomic data A pneumonia outbreak associated with a new coronavirus of 794 probable bat origin proportion. The first four bar plots represent the abundance of archaea in the corresponding category of 874 COVID-19 (BD and China) and non-COVID (URTI; USA and COPD; UK) disease, and the last two bar 875 plots depict overall relative abundance of archaeal genera in COVID-19 and non-COVID metagenomes, 876respectively. Only the 29 most abundant genera are shown in the legend, with the remaining genera grouped 877as 'Other genera'. The distribution and relative abundance of the archaeal genera in the study metagenomes 878are also available in Data S1. genera grouped as 'Other genera'. The distribution and relative abundance of the viral genera in the study 893 metagenomes are also available in Data S1 . 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908